Real world study of Bladder Cancer patients in India
Not Applicable
- Conditions
- Health Condition 1: N33- Bladder disorders in diseases classified elsewhere
- Registration Number
- CTRI/2024/06/068713
- Lead Sponsor
- Pfizer Products India Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients of high risk NMIBC who both initiated treatment and/or diagnosed Jan 2023 onwards.
All patients of metastatic urothelial carcinoma who initiated treatment and/or diagnosed Jan 2023 onwards.
Aged at least 18 years upon diagnosis.
Exclusion Criteria
Previously enrolled in an interventional trial related to High-risk NMIBC or mUC
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method